April 27, 2022Comments Off on Subclonal evolution of CLL driver mutations is associated with relapse in ibrutinib and acalabrutinib treated patients ABSTRACTSubclonal evolution of CLL driver mutations is associated with relapse in ibrutinib and acalabrutinib treated patients Black GS, Huang X, Qiao Y, Tarapcsak S, Rogers KA, Misra S, Byrd JC, Marth GT, Stephens DM, Woyach JA Blood. 2022 Apr 27:blood.2021015132. doi: 10.1182/blood.2021015132. Epub ahead of print. PMID: 35476648.
Comments are closed.